MS: Busting the Myths
February 29, 2024 | Advocacy, Treatments
Pharmac announced, in February, it was looking to extend funded access to Shingrix, the new vaccination for shingles, to immunocompromised people over 18 years old. However, the proposal listed specific treatments and conditions eligible. While we were pleased to see […]
February 29, 2024 | Treatments
In December 2023, Pharmac proposed to decline funding for inactive applications, this included an application to fund Sativex for MS spasticity. MSNZ has written to the Pharmac Board to ask that this application remain live and we be permitted to […]
January 31, 2024 | Education, Life with MS, Progressive, Support, Symptoms, Training, Treatments
We are thrilled to share with you our newest resources. Our Living Well with MS (LWWMS) booklet will provide you with a good overview of what multiple sclerosis is, what causes it, how it is diagnosed, the symptoms and treatment […]
December 20, 2023 | Advocacy, Life with MS, Treatments
On the 1st of October Ocrevus (Ocrelizumab) was finally funded for those with Primary Progressive MS (PPMS) who meet the Pharmac criteria for access. We prepared some information to answer the most common questions we have been receiving. Ocrevus for […]
December 5, 2023 | Carer, Carers, Event, Life with MS, MS Voice, Newsletter, Petition, Support, Treatments, Webinar
Welcome to our November 2023 edition of MS Voice. This month we introduce you to our new banger, invite you to our bladder and bowel health webinar and provide you with up-to-date research and development, amongst other exciting updates. View […]